Cardlytics’ (CDLX) “Hold” Rating Reiterated at Needham & Company LLC

Cardlytics (NASDAQ:CDLXGet Free Report)‘s stock had its “hold” rating reissued by research analysts at Needham & Company LLC in a research note issued on Friday,Benzinga reports.

Several other equities research analysts also recently issued reports on the stock. Evercore ISI began coverage on shares of Cardlytics in a research report on Friday, October 11th. They set an “in-line” rating and a $4.00 price objective for the company. Craig Hallum raised Cardlytics from a “hold” rating to a “strong-buy” rating in a report on Wednesday, November 6th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $6.92.

Check Out Our Latest Stock Analysis on CDLX

Cardlytics Stock Performance

CDLX stock opened at $3.06 on Friday. The firm has a market cap of $155.51 million, a PE ratio of -0.50 and a beta of 1.53. Cardlytics has a 1-year low of $2.76 and a 1-year high of $20.52. The company has a current ratio of 1.18, a quick ratio of 1.18 and a debt-to-equity ratio of 2.40. The business’s 50-day moving average price is $3.72 and its two-hundred day moving average price is $4.58.

Cardlytics (NASDAQ:CDLXGet Free Report) last released its earnings results on Wednesday, November 6th. The company reported ($0.15) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.33) by $0.18. The business had revenue of $67.06 million for the quarter, compared to analyst estimates of $57.77 million. Cardlytics had a negative return on equity of 110.67% and a negative net margin of 93.55%. Cardlytics’s revenue was down 15.1% on a year-over-year basis. During the same quarter in the prior year, the company posted ($0.26) earnings per share. As a group, research analysts forecast that Cardlytics will post -1.52 earnings per share for the current year.

Insider Activity at Cardlytics

In related news, CFO Alexis Desieno sold 25,118 shares of the firm’s stock in a transaction dated Friday, November 15th. The shares were sold at an average price of $3.43, for a total value of $86,154.74. Following the transaction, the chief financial officer now owns 116,481 shares of the company’s stock, valued at approximately $399,529.83. This trade represents a 17.74 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Amit Gupta sold 22,607 shares of the business’s stock in a transaction that occurred on Thursday, October 24th. The stock was sold at an average price of $3.85, for a total value of $87,036.95. Following the sale, the chief executive officer now directly owns 178,519 shares of the company’s stock, valued at $687,298.15. This represents a 11.24 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 69,007 shares of company stock worth $251,297 over the last quarter. Company insiders own 4.40% of the company’s stock.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the stock. Atom Investors LP bought a new stake in Cardlytics during the third quarter worth $33,000. Tallon Kerry Patrick purchased a new position in Cardlytics during the 4th quarter worth $37,000. SG Americas Securities LLC bought a new stake in shares of Cardlytics in the 3rd quarter worth $45,000. Intech Investment Management LLC purchased a new stake in shares of Cardlytics in the third quarter valued at about $47,000. Finally, Quadrature Capital Ltd purchased a new stake in shares of Cardlytics during the 3rd quarter valued at $63,000. Institutional investors own 68.10% of the company’s stock.

Cardlytics Company Profile

(Get Free Report)

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.

See Also

Analyst Recommendations for Cardlytics (NASDAQ:CDLX)

Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.